Forbes J M & Co. LLP held its position in shares of Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 3,130 shares of the conglomerate’s stock at the end of the first quarter. Forbes J M & Co. LLP’s holdings in Danaher Corporation were worth $268,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in DHR. Lathrop Investment Management Corp acquired a new position in shares of Danaher Corporation during the first quarter worth $216,000. Private Trust Co. NA increased its position in shares of Danaher Corporation by 0.3% in the first quarter. Private Trust Co. NA now owns 19,081 shares of the conglomerate’s stock worth $1,632,000 after buying an additional 49 shares in the last quarter. TNB Financial acquired a new position in shares of Danaher Corporation during the first quarter worth $477,000. CrestPoint Capital Management LLC increased its position in shares of Danaher Corporation by 16.7% in the first quarter. CrestPoint Capital Management LLC now owns 7,700 shares of the conglomerate’s stock worth $659,000 after buying an additional 1,100 shares in the last quarter. Finally, Regentatlantic Capital LLC increased its position in shares of Danaher Corporation by 28.9% in the first quarter. Regentatlantic Capital LLC now owns 51,036 shares of the conglomerate’s stock worth $4,365,000 after buying an additional 11,454 shares in the last quarter. 76.12% of the stock is owned by institutional investors and hedge funds.
Shares of Danaher Corporation (NYSE:DHR) opened at 80.87 on Friday. The stock’s 50 day moving average is $82.32 and its 200 day moving average is $84.22. The company has a market capitalization of $56.18 billion, a P/E ratio of 25.81 and a beta of 1.03. Danaher Corporation has a 12 month low of $75.71 and a 12 month high of $88.01.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion for the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the prior year, the firm posted $0.90 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.
WARNING: This story was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://stocknewstimes.com/2017/08/19/forbes-j-m-co-llp-holds-position-in-danaher-corporation-dhr-updated.html.
A number of brokerages have weighed in on DHR. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub raised shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, June 21st. Deutsche Bank AG reissued a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research report on Wednesday, June 21st. Zacks Investment Research downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Monday, June 19th. Finally, Credit Suisse Group reissued a “buy” rating and set a $93.00 price target on shares of Danaher Corporation in a research report on Wednesday, May 24th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $91.76.
In other Danaher Corporation news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of the stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The disclosure for this sale can be found here. Insiders have sold 38,623 shares of company stock worth $3,206,426 over the last three months. 12.20% of the stock is currently owned by insiders.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
